📝 Medico Intercontinental Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Medico Intercontinental Ltd reported revenue of ₹21 crore for the quarter ended June 2026 (Q1 FY27), down 3.0% from ₹21 crore in the same quarter last year, and down 7.9% sequentially over the March 2026 quarter.
The company reported a net loss of ₹4 crore, against a net loss of ₹2 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-1.45.
Operating profit stood at ₹-1 crore — an operating margin (OPM) of -3.3%, compared with 3.2% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Medico Intercontinental Ltd posted revenue of ₹84 crore, a decline of 11.8% over FY25, with a net loss of ₹11 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹83 crore with a net loss of ₹13 crore.
Valuation snapshot
At the current price of ₹25.90, 539938 has a market capitalisation of ₹25 crore.
Within the Trading & Distributors industry, it is the 25th-largest of the 178 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 58.51%, public shareholders 41.48% of Medico Intercontinental Ltd.
Promoter holding rose from 57.15% to 58.51% over the latest period.